Genentech, Inc. Contact Information all trade marks
The Genentech, Inc. owner is known worldwide for his trademarks. These brands are in demand in services such as For: Pharmaceutical oncology preparations International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE Basis: 1(b), For: Pharmaceutical preparations for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disor, For: Pharmaceutical preparations containing trastuzumab emtansine for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, For: Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases a, For: Providing educational training in the medical field International Class(es): 041- Primary Class U.S Class(es): 100,101,107 Class Status: ACTIVE Basis: 1(a) First Use: Feb. 28, 2013 Use in Commerce: Feb. 28, 2013 For: Medical services International C, For: Injection devices for medical purposes International Class(es): 010- Primary Class U.S Class(es): 026,039,044 Class Status: ACTIVE Basis: 1(a) First Use: Nov. 14, 2011 Use in Commerce: Nov. 14, 2011. You can contact Genentech, Inc. from anywhere in the world by phone or email, which you will find on our service. Trademarks presented to you have been re-registered at different times. Key Publication Dates - Oct. 14, 2016, Oct. 28, 2010, May 10, 2010, Apr. 26, 2010, Apr. 29, 2010, Aug. 04, 2010.
